Clinical and prognostic role of the plasma level of stimulating growth factor in patients with miscellaneous cardiovascular pathology

Clinical and prognostic role of the plasma level of stimulating growth factor in patients with miscellaneous cardiovascular pathology

Aim. To determine the clinical and prognostic role of plasma level of stimulating growth factor inmiscellaneouscardiovascular pathology. Material and Methods. There was carried out a review of literature highlighting the clinical and prognostic role of the plasma level of the stimulating growth f...

Full description

Bibliographic Details
Main Authors:	V.P. Ivanov, I.A. Mezhiievska, V.Yu. Maslovskyi
Format:	Article
Language:	English
Published:	Danylo Halytsky Lviv National Medical University 2019-02-01
Series:	Acta Medica Leopoliensia
Subjects:	biomarkers, stimulating growth factor expressed by gene 2, prediction of cardiovascular complications
Online Access:	https://amljournal.com/index.php/journal/article/view/79

Similar Items

Characteristics of anatomic injury of coronary arteries in patients with acute myocardial infarction without ST elevation depending on plasma level of gene 2 growth stimulating factor and risk of adverse even
by: V.P. Ivanov, et al.
Published: (2020-02-01)

Prognostic factors of cardiovascular complications during the heatwave of 2010 (cohort observational study)
by: M D Smirnova, et al.
Published: (2016-06-01)

Editorial: The role of metabolic syndrome and disorders in cardiovascular disease
by: Paola Di Pietro, et al.
Published: (2023-10-01)

Recent Highlights of Research on miRNAs as Early Potential Biomarkers for Cardiovascular Complications of Type 2 Diabetes Mellitus
by: Agnieszka Bielska, et al.
Published: (2021-03-01)

Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis
by: Camellia Torabizadeh, et al.
Published: (2023-05-01)

The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
by: Zarema R. Khismatullina, et al.
Published: (2021-04-01)

Evaluating the Effect of Various Doses of Magnesium Sulfate on Cardiovascular Changing and Stimulating due to Laryngoscopes and Intubation
by: Azim Honarmand, et al.
Published: (2015-08-01)

Circulating mir-199-3p screens the onset of type 2 diabetes mellitus and the complication of coronary heart disease and predicts the occurrence of major adverse cardiovascular events
by: Renjie Ruan, et al.
Published: (2023-11-01)

Predictors of cardiovascular complications in patients with arterial hypertension and comorbid pathology
by: Ilkhom T. Murkamilov, et al.
Published: (2021-12-01)

Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review
by: Paul Philipp Heinisch, et al.
Published: (2022-05-01)

Cardiovascular Response to Vestibular Stimulation in Cyclic, Situational and Stereotypical Complex Coordination Kinds of Sports
by: Abdoulakhat S. Chinkin, et al.
Published: (2014-01-01)

Dynamics of biochemical markers of systemic inflammatory response and renal functional condition in patients with myocardial infarction without ST elevation in the dependence of percutaneous angioplasty
by: V.P. Ivanov, et al.
Published: (2018-12-01)

The dynamics of the functional condition of patients with non Q-wave myocardial infarction with regard to the hospital treatment strategy in the acute period
by: V.P. Ivanov, et al.
Published: (2018-02-01)

The influence of the blocker of mineralocorticoid receptors eplerenone on the dynamics of the structural-functional state of the myocardium in patients with non Q-wave myocardial infarction after 3 and 6 months of treatment
by: V.P. Ivanov, et al.
Published: (2018-09-01)

Character of coronary vasculature lesions in patients with non-Q myocardial infarction in gender and age aspects
by: V.P. Ivanov, et al.
Published: (2017-12-01)

Dynamics of biochemical markers of systemic inflammatory response and renal functional condition in patients with myocardial infarction without ST-elevation in the dependence of the use of the blоcker of mineralocortycoіde receptors of eplerenone for the
by: V.P. Ivanov, et al.
Published: (2019-09-01)

EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS
by: E. V. Akhmedova, et al.
Published: (2015-09-01)

The link between bone disease and cardiovascular complications in hemodialysis patients
by: Noha Elsheikh, et al.
Published: (2016-06-01)

Breast Cancer Treatment and Cardiovascular Considerations
by: Maryam Mehrpooya, et al.
Published: (2018-03-01)

Psoriasis, cardiovascular syndrome and methotrexate
by: Utz S.R., et al.
Published: (2016-09-01)

Preeclampsia – long-term effects on mother and child
by: Małgorzata Wieteska, et al.
Published: (2021-08-01)

The relation of various clinical and instrumental parameters to the character of coronary arteries lesions in patients with myocardial infarction without ST-elevation
by: V.P. Ivanov, et al.
Published: (2016-12-01)

Dynamics of the myocardial structural and functional state in patients with non Q-wave myocardial infarction during 3 and 6 months follow-up in connection with percutaneous angioplasty
by: V.P. Ivanov, et al.
Published: (2018-06-01)

Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases
by: Ilona Hromadnikova, et al.
Published: (2020-03-01)

Bisphenol A (BPA) Leading to Obesity and Cardiovascular Complications: A Compilation of Current In Vivo Study
by: Ruth Naomi, et al.
Published: (2022-03-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United States
by: Chengchen Zhang, et al.
Published: (2021-04-01)

Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
by: Farah Omran, et al.
Published: (2022-05-01)

Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
by: Danni Mu, et al.
Published: (2022-07-01)

A LINK BETWEEN ACTIVE MYELOPEROXIDASE AND CHLORINATED CERULOPLASMIN IN BLOOD PLASMA OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Sokolov, et al.
Published: (2018-11-01)

CARDIOVASCULAR COMPLICATIONS AND ENDOTHELIAL DYSFUNCTION IN PRIMARY VASCULITIS
by: L A Strizhakov, et al.
Published: (2012-05-01)

The value of revascularization and adherence to therapy in the development of cardiovascular complications in long-term monitoring of patients with myocardial infarction of the right ventricle on the background of the Q-myocardial infarction of the left ventricular posterior wall
by: V.Y. Tseluyko, et al.
Published: (2016-03-01)

Lead Fractures after Vagal Nerve Stimulator Implantation
by: Ahmet Eren SEÇEN, et al.
Published: (2019-12-01)

Advancements in understanding inflammatory responses and the development of cardiovascular diseases under cold stimulation
by: Ma Guanpeng, et al.
Published: (2023-12-01)

The Janus-faced role of Piezo1 in cardiovascular health under mechanical stimulation
by: Junyang Huang, et al.
Published: (2023-09-01)

Cardiovascular effects of auricular stimulation -a systematic review and meta-analysis of randomized controlled clinical trials
by: Kevin Hua, et al.
Published: (2023-09-01)

CARDIOVASCULAR COMPLICATIONS RISK AND VASCULAR AGE DYNAMICS IN LONG-TERM TREATMENT OF ARTERIAL HYPERTENSION
by: I. V. Logacheva, et al.
Published: (2016-12-01)

Radiation Therapy Induced Cardiovascular Disease
by: Heath Adams, et al.
Published: (2017-10-01)

Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia
by: Antonella Meloni, et al.
Published: (2024-02-01)

Peripheral Nerve Stimulation in Painful Conditions of the Upper Extremity—An Overview
by: Vincent Yaccarino, et al.
Published: (2022-11-01)